New Zealand markets open in 2 hours 49 minutes

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.72-0.29 (-3.22%)
At close: 04:00PM EST
8.70 -0.02 (-0.23%)
After hours: 05:30PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 446.48M
Enterprise value 271.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.15
Price/book (mrq)2.50
Enterprise value/revenue 6.43
Enterprise value/EBITDA -2.11

Trading information

Stock price history

Beta (5Y monthly) 2.08
52-week change 3-59.20%
S&P500 52-week change 314.07%
52-week high 337.07
52-week low 38.69
50-day moving average 311.35
200-day moving average 316.34

Share statistics

Avg vol (3-month) 3885.64k
Avg vol (10-day) 3832.75k
Shares outstanding 542.52M
Implied shares outstanding 6N/A
Float 835.74M
% held by insiders 19.07%
% held by institutions 174.58%
Shares short (30 Dec 2021) 49M
Short ratio (30 Dec 2021) 49.66
Short % of float (30 Dec 2021) 421.32%
Short % of shares outstanding (30 Dec 2021) 421.18%
Shares short (prior month 29 Nov 2021) 49.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 0.00%
Operating margin (ttm)-305.40%

Management effectiveness

Return on assets (ttm)-32.13%
Return on equity (ttm)-71.14%

Income statement

Revenue (ttm)42.23M
Revenue per share (ttm)1.03
Quarterly revenue growth (yoy)-81.70%
Gross profit (ttm)45.28M
EBITDA -128.48M
Net income avi to common (ttm)-133.68M
Diluted EPS (ttm)-3.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)212.09M
Total cash per share (mrq)4.99
Total debt (mrq)37.32M
Total debt/equity (mrq)20.93
Current ratio (mrq)8.68
Book value per share (mrq)4.19

Cash flow statement

Operating cash flow (ttm)-128.96M
Levered free cash flow (ttm)-78.22M